Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Ferric Citrate: a Managed Care Cost-Offset Model
Download
Mutell R, Rubin JL, Bond TC, Mayne T. Int J Nephrol Renovasc Dis. 2013;6:79-87.